Vinorelbine treatment IND program announced.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D014747:Vinblastine; D000077235:Vinorelbine